NYU Langone Health recorded total revenue of $14.2 billion: 30.8% from inpatient operations; 28.1% from outpatient operations; 19.1% from faculty group practice patient services; and 22% from other sources. Total revenue increased by $1.8 billion or by 14.2% year over year.
Total operating expenses were $13.7 billion: 60.1% salaries and benefits; 32.3% pharmaceutical, medical, and other supplies; 6.0% depreciation and amortization; and 1.6% interest. Total expenses increased by $1.7 billion or 14% year over year.
Days cash on hand for NYU Langone decreased to 144 days on Aug. 31, 2024, compared to 164 days on Aug. 31, 2023. The decrease was primarily driven by capital expenditures to support strategic capital investments.
Net income for fiscal 2024 was $890.5 million, compared to $1.3 billion in fiscal 2023.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
